Akero Therapeutics, based in South San Francisco, is a leading cardio-metabolic biotechnology company.
Specializing in the development of innovative treatments for non-alcoholic steatohepatitis (NASH), Akero Therapeutics is dedicated to transforming the landscape of NASH therapy.
Generated from their website's infomation